TOG Review (RCOG Journal)

MRCOG Part 2

Antenatal Care

Maternal, fetal, and neonatal outcomes associated with long-term use of corticosteroids during pregnancy

Key Statistics

  • 3-fold — Rise in maternal cortisol in pregnancy
  • 5–10× — ↑ Gestational diabetes risk, chronic steroids
  • OR 3.35 — Oral clefts, 1st-trimester exposure

Don't-miss facts

  1. Chronic maternal corticosteroid use does NOT replace a standard fluorinated ACS course if preterm delivery threatens at 24–34 weeks

  2. ACS regimens: betamethasone 12 mg IM ×2 (24h apart) or dexamethasone 6 mg IM ×4 (12h apart); RCOG accepts any regimen totalling 24 mg in 24–48h

  3. Dexamethasone/betamethasone cross placenta readily (poor 11β-HSD2 substrates, only 1.8%/7.1% inactivated) vs cortisol (67% inactivated) and prednisolone (51% inactivated)

  4. ACS ↓RDS: RR 0.66 (95% CI 0.59–0.73) from 21 studies/4269 infants; serial (>2) courses not recommended

  5. 1st-trimester corticosteroid exposure: possible ↑oral clefts (OR 3.35) – but large Danish registry found no increased risk; evidence conflicting

  6. Chronic corticosteroid use → 5–10-fold ↑gestational diabetes risk – offer GTT

  7. Avoid betamethasone in breastfeeding; prefer prednisolone, avoid feed for 4h post-dose

  8. Mifepristone + long-term corticosteroids (e.g. post-transplant) is contraindicated

Placental transfer at a glance

Cross readily: dexamethasone, betamethasone (fluorinated) More placenta-metabolised: cortisol, prednisolone

Abbreviation Key

  • HPA — hypothalamic–pituitary–adrenal (axis)
  • OR — odds ratio
  • CRH — corticotrophin-releasing hormone
  • CI — confidence interval
  • ACTH — adrenocorticotrophin hormone
  • RCOG — Royal College of Obstetricians and Gynaecologists
  • 11β-HSD2 — 11β-hydroxysteroid dehydrogenase type 2
  • ACOG — American College of Obstetricians and Gynecologists
  • RDS — respiratory distress syndrome
  • GTT — glucose tolerance test
  • ACS — antenatal corticosteroids
  • NICU — neonatal intensive care unit
  • RR — risk ratio

Source: AlSaad D et al. Maternal, fetal, and neonatal outcomes associated with long-term use of corticosteroids during pregnancy. The Obstetrician & Gynaecologist 2019;21:117–125. doi:10.1111/tog.12556

MRCOG AI is an independent educational tool. It is not affiliated with, endorsed by, or connected to the Royal College of Obstetricians and Gynaecologists (RCOG).

Included with a Pass Package

  • Audio overview of this guideline
  • Practice questions drawn from it
  • AI tutor answers grounded in its text
  • Your own annotations
Start free